| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |